
IndraLab
Statements
Salicylate inhibits NFKBIA. 2 / 2
|
2
reach
"Furthermore, after TNF-alpha treatment for 0.5 h, Sal B significantly suppressed IkappaBalpha activation (TNF-alpha group vs. control group, P = 0.001; Sal B 1 mumol/L vs. TNF-alpha group, P = 0.048; Sal B 5 mumol/L vs. TNF-alpha group, P = 0.006; Sal B 10 mumol/L vs. TNF-alpha group, P = 0.001)."